197 related articles for article (PubMed ID: 33117604)
1. Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients.
Mo X; Huang X; Feng Y; Wei C; Liu H; Ru H; Qin H; Lai H; Wu G; Xie W; Jeen F; Lin Y; Liu J; Tang W
Oncoimmunology; 2020 Oct; 9(1):1832347. PubMed ID: 33117604
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
4. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy.
Guo XW; Li SQ; Lei RE; Ding Z; Hu BL; Lin R
Front Oncol; 2022; 12():953321. PubMed ID: 36110947
[TBL] [Abstract][Full Text] [Related]
6. An immune infiltration signature to predict the overall survival of patients with colon cancer.
Peng D; Wang L; Li H; Cai C; Tan Y; Xu B; Le H
IUBMB Life; 2019 Nov; 71(11):1760-1770. PubMed ID: 31301220
[TBL] [Abstract][Full Text] [Related]
7. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
8. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
Lv Y; Jin P; Chen Z; Zhang P
Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386
[TBL] [Abstract][Full Text] [Related]
9. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
10. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database].
Ding TT; Zeng CX; Hu LN; Yu MH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):203-208. PubMed ID: 35435180
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma.
Li C; Zou H; Xiong Z; Xiong Y; Miyagishima DF; Wanggou S; Li X
Front Genet; 2020; 11():429. PubMed ID: 32508873
[No Abstract] [Full Text] [Related]
13. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
14. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
15. Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study.
Xiong Y; Wang K; Zhou H; Peng L; You W; Fu Z
Cancer Med; 2018 Sep; 7(9):4496-4508. PubMed ID: 30117315
[TBL] [Abstract][Full Text] [Related]
16. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
17. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
[TBL] [Abstract][Full Text] [Related]
18. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
19. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
20. A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer.
Wang H; Xu F; Zhang M; Liu J; Wang F; Zhao Q
DNA Cell Biol; 2020 Jul; 39(7):1181-1193. PubMed ID: 32397747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]